Biotech · Private company · Portland, OR, US
AgonOx, Inc.
Track this companyFree. Adds AgonOx, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- DP CD8 TILPhase 1 · HNSCCClinicalTrials.gov · fetched Nov 12, 2026
- DP CD8 TIL KDPhase 1 · HNSCCClinicalTrials.gov · fetched Nov 12, 2026
- Low dose IL-2Phase 1 · HNSCCClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Jun 19, 2023ClinicalTrials.gov NCT05902520 · fetched Nov 12, 2026
NIH awards1
- Enriching and expanding tumor-reactive CD8 T-cells to treat breast cancerFiscal year 2026 · $977.6KNIH RePORTER 1R44CA314796-01 · fetched Nov 12, 2026